Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas - PubMed (original) (raw)

Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas

Kavita S Reddy. Cancer Genet Cytogenet. 2008.

Abstract

This study assessed the efficacy of FISH for detecting 1p/19q deletion in gliomas on 77 paraffin-embedded tissue samples, of which 42 cases (55%) were positive for 1p/19q codeletion; 7 of the 42 had a previous history of glioma. In one case, analysis failed. The remaining 34 cases were negative; of these, three had a previous history of glioma and one had the reverse 1q/19p deletion. A majority of the 10 recurrent gliomas had progressed, and 70% had a 1p/19q deletion. The signal pattern in a majority of 1p/19q codeletion cases was a single red marker signal and two green reference signals (1R2G) for both probe sets. One case had a different signal pattern for chromosomes 1 and 19 (1R2G and 2R4G), as seen in polysomy cells. Three cases had two target and four control signals (2R4G), as seen in tetraploid cells. Eleven had complex signal patterns seen in diploid and polyploid cells (1R2G/<nRnG). A majority of these complex cases (8 of 11, or 73%) had high-grade oligodendroglioma (n = 4) or oligoastrocytoma (n = 4). The frequency of 1p/19q combined deletion in oligodendroglioma (n = 40), oligoastrocytoma (n = 21), and astrocytoma (n = 8) was 65, 60, and 25%, respectively. Elucidated in this paper are the various FISH signal patterns observed in gliomas and a need for a uniform nomenclature for improved diagnosis.

PubMed Disclaimer

Cited by

Efficient diagnosis of IDH-mutant gliomas: 1p/19qNET assesses 1p/19q codeletion status using weakly-supervised learning.
Kim GJ, Lee T, Ahn S, Uh Y, Kim SH. Kim GJ, et al. NPJ Precis Oncol. 2023 Sep 16;7(1):94. doi: 10.1038/s41698-023-00450-4. NPJ Precis Oncol. 2023. PMID: 37717080 Free PMC article.
Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven study.
Van der Eecken K, Van der Linden M, Raman L, Creytens D, Dedeurwaerdere F, De Winne K, Ferdinande L, Lammens M, Menten B, Rottiers I, Van Gaever B, Van den Broecke C, Van de Vijver K, Van Roy N, Verbeke S, Van Dorpe J. Van der Eecken K, et al. Virchows Arch. 2022 Mar;480(3):677-686. doi: 10.1007/s00428-022-03268-w. Epub 2022 Jan 16. Virchows Arch. 2022. PMID: 35034191
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas.
Ball MK, Kollmeyer TM, Praska CE, McKenna ML, Giannini C, Raghunathan A, Jentoft ME, Lachance DH, Kipp BR, Jenkins RB, Ida CM. Ball MK, et al. Neurooncol Adv. 2020 Aug 27;2(1):vdaa109. doi: 10.1093/noajnl/vdaa109. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 33205043 Free PMC article.
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors.
Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski CM, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Chen W, Iafrate AJ, Chi AS, Zagzag D, Golfinos JG, Placantonakis DG, Rosenblum M, Ohman-Strickland P, Hameed M, Snuderl M. Chen H, et al. Neuro Oncol. 2019 Sep 6;21(9):1164-1174. doi: 10.1093/neuonc/noz098. Neuro Oncol. 2019. PMID: 31140557 Free PMC article.
Detection of chromosome structural variation by targeted next-generation sequencing and a deep learning application.
Park H, Chun SM, Shim J, Oh JH, Cho EJ, Hwang HS, Lee JY, Kim D, Jang SJ, Nam SJ, Hwang C, Sohn I, Sung CO. Park H, et al. Sci Rep. 2019 Mar 6;9(1):3644. doi: 10.1038/s41598-019-40364-5. Sci Rep. 2019. PMID: 30842562 Free PMC article.

Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas - PubMed (original) (raw)